Andy Hurley
Corporate Officer/Principal at SHIELD THERAPEUTICS PLC
Profile
Andy Hurley currently works at Shield Therapeutics Plc, as Chief Commercial Officer from 2023.
Mr. Hurley also formerly worked at Cytophage Technologies, Inc. (Old), as Director, Sumitomo Pharma America, Inc., as Vice President-Marketing & Commercial Operations, Dyax Corp., as Vice President-Sales & Marketing, Agenus, Inc., as Chief Commercial & Clinical Operations Officer from 2021 to 2022, Ocular Therapeutix, Inc., as Chief Commercial Officer from 2016 to 2017, Capgemini America, Inc., as Principal, and Syneos Health, Inc., as Senior Vice President.
Mr. Hurley received his undergraduate degree from the University of Vermont and undergraduate degree from Elkin B Mccallum Graduate School of Business.
Andy Hurley active positions
Companies | Position | Start |
---|---|---|
SHIELD THERAPEUTICS PLC | Corporate Officer/Principal | 2023-04-09 |
Former positions of Andy Hurley
Companies | Position | End |
---|---|---|
AGENUS INC. | Chief Tech/Sci/R&D Officer | 2022-06-30 |
OCULAR THERAPEUTIX, INC. | Corporate Officer/Principal | 2017-08-31 |
Cytophage Technologies, Inc. (Old)
Cytophage Technologies, Inc. (Old) BiotechnologyHealth Technology Cytophage Technologies, Inc. is a Canadian biotech company that produces bacteriophages, which are organisms that infect and kill bacterial cells. Cytophage is based in Winnipeg, Canada, and Steven Theriault has been the CEO of the private company since 2017. The company's tailor-made bacteriophages are inexpensive, quick to produce, harmless to humans and animals, better for the environment, and highly effective against exposed bacteria. The company is working on a phage nasal spray that goes directly to the area where the SARS-CoV-2 virus infects the body, the mucosal membranes in the nose and throat, to promote the production of antibodies through an adaptive immune response, giving protection from infection. Cytophage's bacteriophages have countless applications in food safety, animal health, and human health, and can be used for the decontamination of hospital surfaces and counters, tools and instruments, beds and curtains, and anywhere else bacterial contamination is a concern. | Director/Board Member | - |
SYNEOS HEALTH, INC. | Corporate Officer/Principal | - |
Capgemini America, Inc.
Capgemini America, Inc. Packaged SoftwareTechnology Services Capgemini America, Inc. engages in the provision of software solutions. It offers outsourcing, consulting, and digital transformation. The company is headquartered in New York, NY. | Corporate Officer/Principal | - |
Training of Andy Hurley
University of Vermont | Undergraduate Degree |
Elkin B Mccallum Graduate School of Business | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
AGENUS INC. | Health Technology |
OCULAR THERAPEUTIX, INC. | Health Technology |
SHIELD THERAPEUTICS PLC | Health Technology |
Private companies | 5 |
---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Health Technology |
Dyax Corp.
Dyax Corp. Pharmaceuticals: MajorHealth Technology Dyax Corp. engages in discovery, development and commercialization of novel biotherapeutics. The company was founded by Henry E. Blair in 1989 and is headquartered in Burlington, MA. | Health Technology |
Capgemini America, Inc.
Capgemini America, Inc. Packaged SoftwareTechnology Services Capgemini America, Inc. engages in the provision of software solutions. It offers outsourcing, consulting, and digital transformation. The company is headquartered in New York, NY. | Technology Services |
Syneos Health, Inc.
Syneos Health, Inc. BiotechnologyHealth Technology Syneos Health, Inc. engages in the provision of biopharmaceutical solutions. It operates through the Clinical Solutions and Commercial Solutions segments. The Clinical Solutions segment offers global services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics that span Phase I to IV of clinical development. It also offers individual services including regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health services, clinical trial diversity, biometrics, and regulatory affairs. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions, and consultancy services. The company was founded in 1998 and is headquartered in Morrisville, NC. | Health Technology |
Cytophage Technologies, Inc. (Old)
Cytophage Technologies, Inc. (Old) BiotechnologyHealth Technology Cytophage Technologies, Inc. is a Canadian biotech company that produces bacteriophages, which are organisms that infect and kill bacterial cells. Cytophage is based in Winnipeg, Canada, and Steven Theriault has been the CEO of the private company since 2017. The company's tailor-made bacteriophages are inexpensive, quick to produce, harmless to humans and animals, better for the environment, and highly effective against exposed bacteria. The company is working on a phage nasal spray that goes directly to the area where the SARS-CoV-2 virus infects the body, the mucosal membranes in the nose and throat, to promote the production of antibodies through an adaptive immune response, giving protection from infection. Cytophage's bacteriophages have countless applications in food safety, animal health, and human health, and can be used for the decontamination of hospital surfaces and counters, tools and instruments, beds and curtains, and anywhere else bacterial contamination is a concern. | Health Technology |
- Stock Market
- Insiders
- Andy Hurley